List of Tables
Table 1. Global Inherited Retinal Disease Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Inherited Retinal Disease Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Inherited Retinal Disease Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Inherited Retinal Disease Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Inherited Retinal Disease Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Inherited Retinal Disease Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Inherited Retinal Disease Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Inherited Retinal Disease Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Inherited Retinal Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inherited Retinal Disease Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inherited Retinal Disease Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Inherited Retinal Disease Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inherited Retinal Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Retinal Disease Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inherited Retinal Disease Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Inherited Retinal Disease Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Inherited Retinal Disease Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Inherited Retinal Disease Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Inherited Retinal Disease Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Inherited Retinal Disease Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Inherited Retinal Disease Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Inherited Retinal Disease Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Inherited Retinal Disease Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Inherited Retinal Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Inherited Retinal Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Inherited Retinal Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Inherited Retinal Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Inherited Retinal Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Inherited Retinal Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Inherited Retinal Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Inherited Retinal Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Inherited Retinal Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Inherited Retinal Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Inherited Retinal Disease Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Inherited Retinal Disease Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Inherited Retinal Disease Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Inherited Retinal Disease Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Inherited Retinal Disease Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Inherited Retinal Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Inherited Retinal Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Inherited Retinal Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Inherited Retinal Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Inherited Retinal Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Inherited Retinal Disease Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Inherited Retinal Disease Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Inherited Retinal Disease Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Inherited Retinal Disease Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Inherited Retinal Disease Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Inherited Retinal Disease Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Inherited Retinal Disease Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Inherited Retinal Disease Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Inherited Retinal Disease Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Inherited Retinal Disease Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Inherited Retinal Disease Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Inherited Retinal Disease Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Inherited Retinal Disease Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Inherited Retinal Disease Treatment Price (US$/Unit) by Type (2019-2024)
Table 59. Global Inherited Retinal Disease Treatment Price (US$/Unit) by Type (2025-2030)
Table 60. Global Inherited Retinal Disease Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Inherited Retinal Disease Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Inherited Retinal Disease Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Inherited Retinal Disease Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Inherited Retinal Disease Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Inherited Retinal Disease Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Inherited Retinal Disease Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Inherited Retinal Disease Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Inherited Retinal Disease Treatment Price (US$/Unit) by Application (2019-2024)
Table 69. Global Inherited Retinal Disease Treatment Price (US$/Unit) by Application (2025-2030)
Table 70. Spark Therapeutics Corporation Information
Table 71. Spark Therapeutics Description and Business Overview
Table 72. Spark Therapeutics Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Spark Therapeutics Inherited Retinal Disease Treatment Product
Table 74. Spark Therapeutics Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Inherited Retinal Disease Treatment Product
Table 79. Novartis Recent Developments/Updates
Table 80. Okuvision Corporation Information
Table 81. Okuvision Description and Business Overview
Table 82. Okuvision Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Okuvision Inherited Retinal Disease Treatment Product
Table 84. Okuvision Recent Developments/Updates
Table 85. NIDEK Corporation Information
Table 86. NIDEK Description and Business Overview
Table 87. NIDEK Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. NIDEK Inherited Retinal Disease Treatment Product
Table 89. NIDEK Recent Developments/Updates
Table 90. Invitae Corporation Information
Table 91. Invitae Description and Business Overview
Table 92. Invitae Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Invitae Inherited Retinal Disease Treatment Product
Table 94. Invitae Recent Developments/Updates
Table 95. ZEISS INTERNATIONAL Corporation Information
Table 96. ZEISS INTERNATIONAL Description and Business Overview
Table 97. ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Product
Table 99. ZEISS INTERNATIONAL Recent Developments/Updates
Table 100. MeiraGTx Corporation Information
Table 101. MeiraGTx Description and Business Overview
Table 102. MeiraGTx Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. MeiraGTx Inherited Retinal Disease Treatment Product
Table 104. MeiraGTx Recent Developments/Updates
Table 105. Neurosoft Corporation Information
Table 106. Neurosoft Description and Business Overview
Table 107. Neurosoft Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Neurosoft Inherited Retinal Disease Treatment Product
Table 109. Neurosoft Recent Developments/Updates
Table 110. Astellas Pharma Corporation Information
Table 111. Astellas Pharma Description and Business Overview
Table 112. Astellas Pharma Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Astellas Pharma Inherited Retinal Disease Treatment Product
Table 114. Astellas Pharma Recent Developments/Updates
Table 115. Bionic Vision Technologies Corporation Information
Table 116. Bionic Vision Technologies Description and Business Overview
Table 117. Bionic Vision Technologies Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bionic Vision Technologies Inherited Retinal Disease Treatment Product
Table 119. Bionic Vision Technologies Recent Developments/Updates
Table 120. Coave Therapeutics Corporation Information
Table 121. Coave Therapeutics Description and Business Overview
Table 122. Coave Therapeutics Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Coave Therapeutics Inherited Retinal Disease Treatment Product
Table 124. Coave Therapeutics Recent Developments/Updates
Table 125. GenSight Biologics Corporation Information
Table 126. GenSight Biologics Description and Business Overview
Table 127. GenSight Biologics Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. GenSight Biologics Inherited Retinal Disease Treatment Product
Table 129. GenSight Biologics Recent Developments/Updates
Table 130. Ionis Pharmaceuticals Corporation Information
Table 131. Ionis Pharmaceuticals Description and Business Overview
Table 132. Ionis Pharmaceuticals Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Ionis Pharmaceuticals Inherited Retinal Disease Treatment Product
Table 134. Ionis Pharmaceuticals Recent Developments/Updates
Table 135. IVERIC BIO Corporation Information
Table 136. IVERIC BIO Description and Business Overview
Table 137. IVERIC BIO Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. IVERIC BIO Inherited Retinal Disease Treatment Product
Table 139. IVERIC BIO Recent Developments/Updates
Table 140. Johnson & Johnson Corporation Information
Table 141. Johnson & Johnson Description and Business Overview
Table 142. Johnson & Johnson Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Johnson & Johnson Inherited Retinal Disease Treatment Product
Table 144. Johnson & Johnson Recent Developments/Updates
Table 145. LKC Technologies Corporation Information
Table 146. LKC Technologies Description and Business Overview
Table 147. LKC Technologies Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. LKC Technologies Inherited Retinal Disease Treatment Product
Table 149. LKC Technologies Recent Developments/Updates
Table 150. Santen Pharmaceutical Corporation Information
Table 151. Santen Pharmaceutical Description and Business Overview
Table 152. Santen Pharmaceutical Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Santen Pharmaceutical Inherited Retinal Disease Treatment Product
Table 154. Santen Pharmaceutical Recent Developments/Updates
Table 155. He Eye Hospital Corporation Information
Table 156. He Eye Hospital Description and Business Overview
Table 157. He Eye Hospital Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. He Eye Hospital Inherited Retinal Disease Treatment Product
Table 159. He Eye Hospital Recent Developments/Updates
Table 160. Bgi Genomics Corporation Information
Table 161. Bgi Genomics Description and Business Overview
Table 162. Bgi Genomics Inherited Retinal Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Bgi Genomics Inherited Retinal Disease Treatment Product
Table 164. Bgi Genomics Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Inherited Retinal Disease Treatment Distributors List
Table 168. Inherited Retinal Disease Treatment Customers List
Table 169. Inherited Retinal Disease Treatment Market Trends
Table 170. Inherited Retinal Disease Treatment Market Drivers
Table 171. Inherited Retinal Disease Treatment Market Challenges
Table 172. Inherited Retinal Disease Treatment Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inherited Retinal Disease Treatment
Figure 2. Global Inherited Retinal Disease Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Inherited Retinal Disease Treatment Market Share by Type in 2023 & 2030
Figure 4. Gene Therapy Product Picture
Figure 5. Artificial Retina Product Picture
Figure 6. Neuroprotectant Product Picture
Figure 7. Global Inherited Retinal Disease Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Inherited Retinal Disease Treatment Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Inherited Retinal Disease Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Inherited Retinal Disease Treatment Market Size (2019-2030) & (US$ Million)
Figure 13. Global Inherited Retinal Disease Treatment Sales (2019-2030) & (K Units)
Figure 14. Global Inherited Retinal Disease Treatment Average Price (US$/Unit) & (2019-2030)
Figure 15. Inherited Retinal Disease Treatment Report Years Considered
Figure 16. Inherited Retinal Disease Treatment Sales Share by Manufacturers in 2023
Figure 17. Global Inherited Retinal Disease Treatment Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Inherited Retinal Disease Treatment Players: Market Share by Revenue in 2023
Figure 19. Inherited Retinal Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Inherited Retinal Disease Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Inherited Retinal Disease Treatment Sales Market Share by Country (2019-2030)
Figure 22. North America Inherited Retinal Disease Treatment Revenue Market Share by Country (2019-2030)
Figure 23. United States Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Inherited Retinal Disease Treatment Sales Market Share by Country (2019-2030)
Figure 26. Europe Inherited Retinal Disease Treatment Revenue Market Share by Country (2019-2030)
Figure 27. Germany Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Inherited Retinal Disease Treatment Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Inherited Retinal Disease Treatment Revenue Market Share by Region (2019-2030)
Figure 34. China Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Inherited Retinal Disease Treatment Sales Market Share by Country (2019-2030)
Figure 42. Latin America Inherited Retinal Disease Treatment Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Inherited Retinal Disease Treatment Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Inherited Retinal Disease Treatment Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Inherited Retinal Disease Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Inherited Retinal Disease Treatment by Type (2019-2030)
Figure 52. Global Revenue Market Share of Inherited Retinal Disease Treatment by Type (2019-2030)
Figure 53. Global Inherited Retinal Disease Treatment Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Inherited Retinal Disease Treatment by Application (2019-2030)
Figure 55. Global Revenue Market Share of Inherited Retinal Disease Treatment by Application (2019-2030)
Figure 56. Global Inherited Retinal Disease Treatment Price (US$/Unit) by Application (2019-2030)
Figure 57. Inherited Retinal Disease Treatment Value Chain
Figure 58. Inherited Retinal Disease Treatment Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
